Intent to Grant an Exclusive License of U.S. Government-Owned Inventions, 34968 [2011-14802]

Download as PDF 34968 Federal Register / Vol. 76, No. 115 / Wednesday, June 15, 2011 / Notices 96814–4700; phone (808) 944–2200; fax (808) 973–2941. Written comments or requests for a public hearing on this request should be submitted to the Chief, Permits, Conservation and Education Division, at the address listed above. Comments may also be submitted by facsimile to (301) 713–0376, or by e-mail to NMFS.Pr1Comments@noaa.gov. Please include the File No. in the subject line of the e-mail comment. Those individuals requesting a hearing should set forth the specific reasons why a hearing on this particular modification request would be appropriate. FOR FURTHER INFORMATION CONTACT: Amy Hapeman or Kristy Beard, (301) 713–2289. The subject modification to Permit No. 10027, issued on July 30, 2008 (73 FR 44224), is requested under the authority of the Endangered Species Act of 1973, as amended (16 U.S.C. 1531 et seq.) and the regulations governing the taking, importing, and exporting of endangered and threatened species (50 CFR 222– 226). The permit currently authorizes the permit holder to study the population biology and connectivity of green (Chelonia mydas) and hawksbill (Eretmochelys imbricata) sea turtles focusing on distribution and abundance, ecology, health, and threats to sea turtles at the Palmyra Atoll in the Pacific Ocean. The permit holder requests a modification to their existing permit to increase the number of green sea turtles taken annually from 100 to 250 turtles per year. Of the total 250 green sea turtles, researchers request to increase the number tagged with sonic transmitters from 30 to 40 turtles annually. The modification is needed to accommodate higher than anticipated capture rates and an increase in capture efforts. These data will help determine if temporal, stage-specific, or sexspecific movement patterns exist for the population of sea turtles at Palmyra. The modified permit would expire July 31, 2013. jlentini on DSK4TPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: June 10, 2011. Tammy C. Adams, Acting Chief, Permits, Conservation and Education Division, Office of Protected Resources, National Marine Fisheries Service. [FR Doc. 2011–14857 Filed 6–14–11; 8:45 am] BILLING CODE 3510–22–P VerDate Mar<15>2010 16:42 Jun 14, 2011 Jkt 223001 Department of the Army Intent to Grant an Exclusive License of U.S. Government-Owned Inventions April 20, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: DEPARTMENT OF DEFENSE Department of the Army, DoD. Notice. AGENCY: ACTION: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant an exclusive, revocable license to the invention claimed in the PCT/US2009/060091 (Publication Number WO 2010/042780), entitled ‘‘Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus’’, to Biomedisyn Corporation with its principal place of business at 12 Indian Trail Road, Woodbridge, Connecticut 06525. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619–6664. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808; both at telefax (301) 619– 5034. SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES). SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to a dynamic exoskeletal orthosis applied to the leg below the knee, designed to compensate for weakness, pain, and/or decreased range of motion at the ankle. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2011–14803 Filed 6–14–11; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus AGENCY: Department of the Army, DoD. Notice. Brenda S. Bowen, Army Federal Register Liaison Officer. ACTION: [FR Doc. 2011–14802 Filed 6–14–11; 8:45 am] SUMMARY: BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially; Exclusive Licensing of an Invention Concerning the Intrepid Dynamic Exoskeletal Orthosis Department of the Army, DoD. Notice. AGENCY: ACTION: Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/518,801, entitled ‘‘Intrepid Dynamic Exoskeletal Orthosis (IDEO),’’ filed on SUMMARY: PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 Announcement is made of the availability for licensing of the invention set forth in the PCT/US2009/ 060091, entitled ‘‘Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus’’ filed on October 9, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention. U.S. and selected foreign rights are available. Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, MD 21702–5012. ADDRESSES: For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619–6664. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) FOR FURTHER INFORMATION CONTACT: E:\FR\FM\15JNN1.SGM 15JNN1

Agencies

[Federal Register Volume 76, Number 115 (Wednesday, June 15, 2011)]
[Notices]
[Page 34968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14802]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent to Grant an Exclusive License of U.S. Government-Owned 
Inventions

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) 
and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant 
an exclusive, revocable license to the invention claimed in the PCT/
US2009/060091 (Publication Number WO 2010/042780), entitled ``Methods 
and Compositions for Treating Status Epilepticus and Seizures Causing 
Status Epilepticus'', to Biomedisyn Corporation with its principal 
place of business at 12 Indian Trail Road, Woodbridge, Connecticut 
06525.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research & Technology Applications, (301) 619-6664. For 
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808; 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this 
license can file written objections along with supporting evidence, if 
any, within 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-14802 Filed 6-14-11; 8:45 am]
BILLING CODE 3710-08-P